Privacy Policy
Signals Blog

Contributors

Categories

Retinal degenerative diseases theme of StemCellTalks 2019

Eleni Kanavas is a science communicator with more than eight years of work experience in the academic and health science fields. She is the Acting Communications Specialist at CCRM. She completed her Honours Bachelor’s Degree in Journalism at the University of Toronto...

Right Turn: Curing Canavan Disease with gene therapy

Rare diseases are defined as such because the number of people affected by them is considered very low. Depending on which country you live in, that number will change. There are so many rare diseases in the world that if you add up the number of people living with...

The great experiment: CAR T in Canada

September 5th, 2018, marked a momentous day for Canadian health care as Novartis announced Health Canada’s approval of Kymriah™, the first genetically manipulated cell therapy to be approved in Canada. With the ability of CAR Ts like Kymriah to treat and, potentially...

Right Turn: A top 10 list for 2018 blogs

It’s the time of year when media either look forward, with predictions, or backwards to highlight what resonated with readers. (In 2016, I provided a list of my top five favourite posts, not yours, in case you’d like to check it out.) Since you are a quiet bunch in...